Luis
Manzano Espinosa
Catedrático/a de Universidad
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (13)
2023
-
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
Scientific Reports, Vol. 13, Núm. 1
2022
-
Challenges in managing patients with heart failure with reduced ejection fraction
Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 1-7
-
Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry
Seminars in Arthritis and Rheumatism, Vol. 55
-
Prone Position in COVID-19 Patients With Severe Acute Respiratory Distress Syndrome Receiving Conventional Oxygen Therapy: A Retrospective Study
Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 277-280
-
Vericiguat in heart failure: from scientific evidence to clinical practice
Revista Clinica Espanola
-
Vericiguat in heart failure: from scientific evidence to clinical practice
Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 359-369
-
Vericiguat: VICTORIA trial results
Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 15-22
2021
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
-
Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY model
Clinical Microbiology and Infection, Vol. 27, Núm. 12, pp. 1838-1844
2019
-
Correction to: Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalised older patients with atrial fibrillation (Internal and Emergency Medicine, (2019), 14, 1, (59-69), 10.1007/s11739-018-1938-3)
Internal and Emergency Medicine
-
Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalised older patients with atrial fibrillation
Internal and Emergency Medicine, Vol. 14, Núm. 1, pp. 59-69
2017
-
Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project
ESC Heart Failure, Vol. 4, Núm. 2, pp. 130-137
2014
-
¿se ha incrementado el uso de bloqueadores beta en pacientes con insuficiencia cardiaca en medicina interna? Implicaciones pronósticas: registro RICA
Revista Espanola de Cardiologia, Vol. 67, Núm. 3, pp. 196-202